ArticleCancer chemotherapy and pharmacology2015

Parallel phase Ib studies of two schedules of buparlisib (BKM120) plus carboplatin and paclitaxel (q21 days or q28 days) for patients with advanced solid tumors.

David M Hyman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.